A previous study has distinguished five genes modeling ACC using TOP2A, NDC80, CEP55, CDKN3 and CDK1, which may be utilized to form a board of progressive and predictive biomarkers for ACC for clinical purpose (Xiao et al., 2018). The gene discussed is TOP2A; the disease is adrenal cortex carcinoma.